Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shimabukuro

Showing results (81-90 of 115) with videos related to

Pageof 12
Sort By:
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021David K Shay, Julianne Gee, John R Su, et al.
MMWR. Morbidity and Mortality Weekly Report|January 12, 2023
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|June 8, 2023
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 23, 1997
High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65H Akamine, I Komiya, T Shimabukuro, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2021
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021Anne M Hause, Julianne Gee, James Baggs, et al.
Vaccine|May 29, 2023
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety officeElaine R Miller, Pedro L Moro, Tom T Shimabukuro, et al.
Pageof 12

Showing results (81-90 of 115) with videos related to

Sort By:
Pageof 12
MMWR. Morbidity and Mortality Weekly Report|May 6, 2021
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine - United States, March-April 2021David K Shay, Julianne Gee, John R Su, et al.
MMWR. Morbidity and Mortality Weekly Report|January 12, 2023
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|June 8, 2023
Safety Monitoring of mRNA COVID-19 Vaccine Third Doses Among Children Aged 6 Months-5 Years - United States, June 17, 2022-May 7, 2023Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|November 3, 2022
Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Persons Aged ≥12 Years - United States, August 31-October 23, 2022Anne M Hause, Paige Marquez, Bicheng Zhang, et al.
MMWR. Morbidity and Mortality Weekly Report|March 3, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Persons Aged 12-17 Years - United States, December 9, 2021-February 20, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|July 14, 2022
Safety Monitoring of COVID-19 mRNA Vaccine First Booster Doses Among Persons Aged ≥12 Years with Presumed Immunocompromise Status - United States, January 12, 2022-March 28, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|September 23, 1997
High prevalence of GAD65 (and IA-2) antibodies in Japanese IDDM patients by a new immunoprecipitation assay based on recombinant human GAD65H Akamine, I Komiya, T Shimabukuro, et al.
MMWR. Morbidity and Mortality Weekly Report|February 17, 2022
Safety Monitoring of COVID-19 Vaccine Booster Doses Among Adults - United States, September 22, 2021-February 6, 2022Anne M Hause, James Baggs, Paige Marquez, et al.
MMWR. Morbidity and Mortality Weekly Report|August 5, 2021
COVID-19 Vaccine Safety in Adolescents Aged 12-17 Years - United States, December 14, 2020-July 16, 2021Anne M Hause, Julianne Gee, James Baggs, et al.
Vaccine|May 29, 2023
COVID-19 vaccine safety inquiries to the centers for disease control and prevention immunization safety officeElaine R Miller, Pedro L Moro, Tom T Shimabukuro, et al.
Pageof 12